Growth Hormone Treatment Recruiting Phase 4 Trials for Somatotropin (DB00052)

IndicationStatusPhase
DBCOND0043256 (Growth Hormone Treatment)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05144035
A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA InfantsTreatment
NCT06448195
Effects of Growth Hormone Therapy on Metabolic Function in Fatty Liver Post-Pituitary Adenoma SurgeryTreatment